Bio-Techne Corp
NASDAQ:TECH

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
NASDAQ:TECH
Watchlist
Price: 58.51 USD -2.9% Market Closed
Market Cap: 9.1B USD

Wall Street
Price Targets

TECH Price Targets Summary
Bio-Techne Corp

Wall Street analysts forecast TECH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TECH is 70.79 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

Lowest
Price Target
60.6 USD
4% Upside
Average
Price Target
70.79 USD
21% Upside
Highest
Price Target
78.75 USD
35% Upside
Bio-Techne Corp Competitors:
Price Targets
300463
Maccura Biotechnology Co Ltd
36% Upside
IQV
IQVIA Holdings Inc
15% Upside
STVN
Stevanato Group SpA
42% Upside
OABI
OmniAb Inc
248% Upside
603108
Shanghai Runda Medical Technology Co Ltd
63% Upside
SFZN
Siegfried Holding AG
54% Upside
NANOFH
Nanoform Finland Oyj
165% Upside

Revenue
Forecast

Revenue Estimate
Bio-Techne Corp

For the last 13 years the compound annual growth rate for Bio-Techne Corp's revenue is 11%. The projected CAGR for the next 3 years is 7%.

11%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bio-Techne Corp

For the last 13 years the compound annual growth rate for Bio-Techne Corp's operating income is 3%. The projected CAGR for the next 3 years is 25%.

3%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-29%
Average Miss

Net Income
Forecast

Net Income Estimate
Bio-Techne Corp

For the last 13 years the compound annual growth rate for Bio-Techne Corp's net income is -3%. The projected CAGR for the next 3 years is 78%.

-3%
Past Growth
78%
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TECH's stock price target?
Price Target
70.79 USD

According to Wall Street analysts, the average 1-year price target for TECH is 70.79 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

What is Bio-Techne Corp's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Bio-Techne Corp's revenue is 11%. The projected CAGR for the next 3 years is 7%.

What is Bio-Techne Corp's Operating Income forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Bio-Techne Corp's operating income is 3%. The projected CAGR for the next 3 years is 25%.

What is Bio-Techne Corp's Net Income forecast?
Projected CAGR
78%

For the last 13 years the compound annual growth rate for Bio-Techne Corp's net income is -3%. The projected CAGR for the next 3 years is 78%.

Back to Top